Transcriptional profiling of multiple sclerosis: towards improved diagnosis and treatment (Q36670935)

15 August 2017

1 reference

title

Transcriptional profiling of multiple sclerosis: towards improved diagnosis and treatment (English)

1 reference

15 August 2017

0 references

2

Ludwig Kappos

1 reference

15 August 2017

Raija L P Lindberg

1

1 reference

15 August 2017

1 November 2006

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

15 August 2017

1 reference

15 August 2017

6

1 reference

15 August 2017

6

1 reference

15 August 2017

843-855

1 reference

Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy.

15 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

Natural history of multiple sclerosis: implications for counselling and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

Diverse targets for intervention during inflammatory and neurodegenerative phases of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

Interventions for the prevention of brain atrophy in multiple sclerosis : current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

Transcriptional analysis of targets in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

Analysis of gene expression in mutiple sclerosis lesions using cDNA microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

Quantitative and qualitative changes in gene expression patterns characterize the activity of plaques in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

Multiple sclerosis as a generalized CNS disease--comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

Microarray gene expression profiling of chronic active and inactive lesions in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

An examination of MS candidate genes identified as differentially regulated in multiple sclerosis plaque tissue, using absolute and comparative real-time Q-PCR analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

DNA microarrays in medical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

Up-regulation of osteopontin and alphaBeta-crystallin in the normal-appearing white matter of multiple sclerosis: an immunohistochemical study utilizing tissue microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

Heat shock or stress proteins and their role as autoantigens in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

In vivo gene expression revealed by cDNA arrays: the pattern in relapsing-remitting multiple sclerosis patients compared with normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

Complex immunomodulatory effects of interferon-beta in multiple sclerosis include the upregulation of T helper 1-associated marker genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

Expression profiling identifies responder and non-responder phenotypes to interferon-beta in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

Genomic effects of IFN-beta in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

Microarray detection of E2F pathway activation and other targets in multiple sclerosis peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

Blood transcriptional signatures of multiple sclerosis: unique gene expression of disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

CYFIP2 is highly abundant in CD4+ cells from multiple sclerosis patients and is involved in T cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

Transcription-based prediction of response to IFNbeta using supervised computational methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

Individuality and variation in gene expression patterns in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

Individual-specific variation of gene expression in peripheral blood leukocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

The immune response to mycobacterial 70-kDa heat shock proteins frequently involves autoreactive T cells and is quantitatively disregulated in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

Control of mRNA decay by heat shock-ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

Tissue classification with gene expression profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

Differential and trajectory methods for time course gene expression data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

Microarray analysis identifies a set of CXCR3 and CCR2 ligand chemokines as early IFNbeta-responsive genes in peripheral blood lymphocytes in vitro: an implication for IFNbeta-related adverse effects in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

DNA microarray technology for target identification and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

Human ATP-binding cassette transporter TaqMan low-density array: analysis of macrophage differentiation and foam cell formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.843

21 January 2018

Identifiers

DOI

10.1586/14737159.6.6.843

1 reference

15 August 2017

1 reference

PubMed ID

17140371